Merck KGaA
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MKGAF research report →
Companywww.merckgroup.com/en
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
- CEO
- Belen Garijo Lopez
- IPO
- 2012
- Employees
- 59,020
- HQ
- Darmstadt, DE
Price Chart
Valuation
- Market Cap
- $62.17B
- P/E
- 21.07
- P/S
- 2.55
- P/B
- 1.79
- EV/EBITDA
- 9.81
- Div Yield
- 1.79%
Profitability
- Gross Margin
- 58.53%
- Op Margin
- 19.41%
- Net Margin
- 12.09%
- ROE
- 8.77%
- ROIC
- 7.15%
Growth & Income
- Revenue
- $21.09B · -0.29%
- Net Income
- $2.61B · -6.12%
- EPS
- $6.00 · -6.10%
- Op Income
- $4.06B
- FCF YoY
- -2.28%
Performance & Tape
- 52W High
- $159.34
- 52W Low
- $116.68
- 50D MA
- $132.13
- 200D MA
- $136.90
- Beta
- 0.78
- Avg Volume
- 840
Get TickerSpark's AI analysis on MKGAF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MKGAF Coverage
We haven't published any research on MKGAF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MKGAF Report →